ViiV Healthcare's two-drug HIV pill Dovato (dolutegravir/lamivudine) has matched the efficacy of Gilead's market-leading ...
US obesity specialist Ambrosia Biosciences has strengthened its clinical and scientific ranks, naming cardiometabolic drug ...
UK pharma major GSK reported better-than-expected second-quarter 2026 results, helped by continued growth in Specialty ...
US biotech Apnimed has set the terms for its long-awaited initial public offering, seeking to raise up to $150 million as it prepares for a potential commercial launch of its lead obstructive sleep ...
Positive high-level results from the CLARITY-Gastric01 global Phase III trial showed that sonesitatug vedotin (Sone-Ve) ...
Shares of US biotech Forte Biosciences shot up nearly 40% to $76.40 in early trading, on the news of a takeover bid from ...
US biotech Outlook Therapeutics revealed that the US Food and Drug Administration (FDA) has approved Lytenava ...
Cambridge, USA-based biotech Oak Hill Bio this morning announced plans to go public via a combination with RA Capital-backed ...
UK-based Novogene Europe, a multiomics research services partner, today announced that it has expanded its single-cell RNA ...
Among significant news last week, Halozyme Therapeutics struck a license agreement for its INCA033989 with fellow USA-based ...
Swiss contract development and manufacturing group Lonza today reported sales of 3.4 billion francs ($4.25 billion) in the ...
US pharma major Johnson & Johnson has reported positive top-line Phase III data showing that a dual bispecific antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results